Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app aims to sharpen listening skills for hearing aid users

NCT ID NCT05329922

Symptom relief Sponsor: Universitaire Ziekenhuizen KU Leuven Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested the ALICE app, a smartphone tool designed to train listening and communication skills in people with hearing loss. 161 adults who already use hearing aids or cochlear implants used the app alongside their usual care. The goal was to see if the app could improve their ability to understand speech in noisy environments, measured by speech tests and questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ALICE app (auditory rehabilitation training)
What this could lead to
If it works, this could provide a free app-based tool to help people with hearing loss better understand conversations in noisy settings.
What could go wrong
This is a completed trial, but the app is an add-on to standard care, not a replacement. Benefits may be small and not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

161 people

The number who actually took part.

Started

Oct 2022

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (Experienced hearing aid/cochlear implant users): * Clients with a hearing aid or cochlear implant. * Clients with a hearing aid must have completed the hearing aid trial period and must have decided to purchase the hearing aid. * Clients with a cochlear implant must have at least 6 months of experience with the implant. * Clients who experience listening and communication difficulties. * Clients may not have any experience with auditory training yet. * Able to operate the training programme as an app on a mobile device/tablet (e.g. clients have a mobile device or table; clients have sufficient eyesight to see the exercises; clients must be able operate the programme). * At least 18 years old. * Arm 1: Dutch-speaking as all training material and counselling questions will be presented in Dutch. * Arm 3: French-speaking as all training material and counselling questions will be presented in French. * Clients need to have an Android or iPhone smart device and connection to internet Inclusion Criteria (New hearing aid users): * Clients who are starting their hearing aid trial as a first time hearing aid user (N= 120). Which is more than necessary according to the power analysis (3.5.7). * Clients who experience listening and communication difficulties * Able to operate the training programme as an app on a mobile device/tablet (e.g. clients have a mobile device or table; clients have sufficient eyesight to see the exercises; clients must be able operate the programme). * At least 18 years old. * Dutch-speaking as all training material and counselling questions will be presented in Dutch * Clients need to have an Android or iPhone smartphone and connection to internet Exclusion Criteria (Both groups): * Visually impaired * Motorically impaired * Cognitively impaired

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hearing disability are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hearing disability

Contacts and locations

Locations

  • KU Leuven, Experimental ORL, Dept Neurosciences

    Leuven, VLAAMS BRABANT, 3001, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.